Oncology: A Case Study in Innovation & Access From the promise of personalized medicine to a shift toward more targeted treatments, panelists discuss the development of new cancer therapies and the innovations that lie ahead. The panel also explores how public policy shapes, fosters and creates challenges for biomedical innovation in oncology.

Moderator: Dr. Anthony Coles, CEO, Onyx Pharmaceuticals Dr. Robert Figlin, Head of Oncology, Cedars Sinai Health Systems Dr. Risa Stack, Partner, Kleiner Perkins Caufield & Byers Nancy Bradish Myers, President and Founder, Catalyst Healthcare Consulting David Nelson, CEO, Epic Sciences